久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > Access
Access
Access Access

美國Access Pharmaceuticals
美國癌癥患者護理公司Access Pharmaceuticals 治療癌癥患者口腔粘膜炎的MuGard

Access Pharmaceuticals is an emerging biopharmaceutical company specializing in products for cancer and supportive care. Access currently has one FDA-approved product, two products in Phase II clinical development, three products in preclinical development. Several of the company's products are based on Access' proprietary nanopolymer technologies which provide enhanced drug delivery options for both new and approved pharmaceutical active ingredients.
While its primary focus is in oncology, Access' drug delivery technologies also yield candidates that enable and enhance the absorption of drugs by exploiting the body's own vitamin B-12 absorption system.
Mucositis is a frequent side-effect of cancer therapy for which there is no established treatment. MuGard ? is Access' approved proprietary nanopolymer formulation for the management of mucositis. This ready–to–use rinse provides a soothing oral coating. A clinical study has shown that when MuGard is used by patients at the start of cancer therapy, the incidence and severity of mucositis are reduced. MuGard is available in Europe by prescription through Access' marketing partner, SpePharm. Access will be marketing MuGard in the United States in 2010, and marketing partners in Asia are advancing Regulatory approval of MuGard in South Korea and China.


Access is focusing its development effort on three products/technologies: ProLindac ?, Thiarabine, and Cobalamin ?. The company's lead development candidate for the treatment of cancer is ProLindac ?, a nanopolymer DACH platinum prodrug. ProLindac has successfully completed a European Phase II trial in patients with ovarian cancer, and Access and its Asian partners are planning to start Phase II combination studies shortly. Oxaliplatin (Eloxatin, Sanofi-Aventis) is the only DACH platinum currently approved; it has sales in excess of $2 billion.
Thiarabine; is a Phase II nucleoside analog with considerable potential for treatment of lymphoma and leukemia. Extensive preclinical data shows that Thiarabine has good efficacy in a variety of tumor models.
Cobalamin ?; is Access' proprietary nanopolymer oral drug delivery technology. Using a 'Trojan Horse' approach, the technology uses the body's natural vitamin B12 uptake mechanism in the gut to transport drugs that otherwise would have little or no oral bioavailability. The company is currently developing products for the oral delivery of insulin and human growth hormone (HGH), and is collaborating with a number of companies to develop additional formulations of various other pharmaceutically-active compounds.

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 亚洲国产成人久久综合野外 | 亚洲国产一区二区三区在线观看 | 99久久精品免费国产一区二区三区 | 在线观看免费国产视频 | 日韩欧美国产高清在线观看 | 国产一级持黄大片99久久 | 美女一级a毛片免费观看 | 亚洲第七页 | 欧美性一区二区三区五区 | 国产毛片久久久久久国产毛片 | www.欧美色图| 亚洲欧美日韩综合精品网 | 99精品视频在线观看免费 | 国产靠逼视频 | 欧美 亚洲 校园 第一页 | 亚洲一二三区视频 | 国产成人久久一区二区三区 | 亚洲欧美日韩另类精品一区二区三区 | 日韩欧美国产精品第一页不卡 | 久久久久久久久国产 | 亚洲午夜久久久久中文字幕 | 福利视频一区二区三区 | 最近免费中文字幕大全免费版视频 | 日本一区二区视频在线观看 | 欧美成人猛男性色生活 | 精品视频在线观看视频免费视频 | 精品一区二区三区视频日产 | 亚洲综合欧美在线 | 国产色综合久久无码有码 | 一区二区中文字幕 | 国产高清免费在线观看 | 国产一级特黄高清免费大片dvd | 黄色a免费| 日日草视频 | 九九国产精品九九 | 亚洲欧美久久精品一区 | 日韩在线播放一区 | 亚州一区二区 | 亚洲成人一区二区 | 欧美一区二区在线视频 | 精品72久久久久久久中文字幕 |